|
|
Thomson Financial Business Description:
| The Group's principal activity is to discover, develop and market products to treat neurological disorders and cancers. The Group researches to develop suitable drugs in treatment of neurological disorders like ALS, narcolepsy, peripheral neuropathies, head and spinal injury, Alzheimer's and stroke. Its products are Provigil(R),FENTORA, ACTIQ (R), NUVIGIL and GABITRIL (R). Provigil tablets are used by those suffering from excessive daytime sleepiness associated with narcolepsy; ACTIQ (R), for the management of breakthrough cancer pain in opioid tolerant patients and the further development of Gabitril (R), an adjunctive treatment for partial seizures associated with epilepsy. The Group operates in the United States, France, the United Kingdom, Germany, Italy, the Netherlands and Switzerland. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Cephalon, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
